Remodulin

NDC 66302-114 · United Therapeutics Corporation

Generic nametreprostinil

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)TREPROSTINIL

Strength8 mg/20mL

Pharmacologic classProstacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]

Marketing categoryNDA

Packages

66302-114-01 — 1 VIAL in 1 BOX (66302-114-01) / 20 mL in 1 VIAL

J3285 — Injection, treprostinil, 1 mg Medicare Part B payment limit (ASP + 6%): $54.74

FDA lists these products with the same active ingredient.

43598-648 — Treprostinil, 43598-649 — Treprostinil, 62332-514 — Treprostinil, 62332-515 — Treprostinil, 62332-516 — Treprostinil, 62332-517 — Treprostinil, 66302-101 — treprostinil, 66302-102 — treprostinil, 66302-105 — treprostinil, 66302-110 — treprostinil, 66302-206 — treprostinil, 66302-300 — treprostinil, 66302-302 — treprostinil, 66302-310 — treprostinil, 66302-325 — treprostinil, 66302-350 — treprostinil, 66302-616 — treprostinil, 66302-632 — treprostinil, 66302-648 — treprostinil, 66302-664 — treprostinil, +16 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.